# Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults

> **NCT05653479** · PHASE1 · COMPLETED · sponsor: **Upstream Bio Inc.** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** UPB-101

## Key facts

- **NCT ID:** NCT05653479
- **Lead sponsor:** Upstream Bio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-05
- **Primary completion:** 2023-04-07
- **Final completion:** 2023-05-13
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2024-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05653479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05653479, "Safety and Blood Levels After a Single Injection of UPB-101 in Healthy Japanese and Non-Japanese Non-East Asian Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05653479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*